Jm Medsurge Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 2.33 M
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2019
- Open Charges ₹ 2.00 M
- Revenue Growth %
- Profit Growth -308.60%
- Net Worth -35.67%
- Total Assets -60.83%
About Jm Medsurge
Jm Medsurge Private Limited (JMPL) is a Private Limited Indian Non-Government Company incorporated in India on 27 August 2004 and has a history of 20 years and five months. Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.33 M.
The company currently has active open charges totaling ₹2.00 M.
Jayant Fadnavis, Smita Fadnavis, Avinash Fadnavis, and One other member serve as directors at the Company.
Company Details
-
Location
Nagpur, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U33110MH2004PTC148256
-
Company No.
148256
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
27 Aug 2004
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Jm Medsurge?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayant Fadnavis
|
Managing Director | 27-Aug-2004 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Smita Fadnavis
|
Director | 27-Aug-2004 | Current |
|
Avinash Fadnavis
|
Director | 01-Mar-2005 | Current |
|
Shailesh Fadnavis
|
Director | 01-Mar-2005 | Current |
Financial Performance of Jm Medsurge.
Jm Medsurge Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 308.6% decrease in profit. The company's net worth observed a substantial decline by a decrease of 35.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jm Medsurge?
In 2017, Jm Medsurge had a promoter holding of 51.61% and a public holding of 48.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Psybus Life Sciences LlpJayant Fadnavis is a mutual person
Charges (Loans)
₹2.00 M
₹0
Charges Breakdown by Lending Institutions
- Industrial Development Bank Of India Limited : 0.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jan 2007 | Industrial Development Bank Of India Limited | ₹2.00 M | Open |
How Many Employees Work at Jm Medsurge?
Unlock and access historical data on people associated with Jm Medsurge, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jm Medsurge, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jm Medsurge's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.